SARS-CoV-2 infection in patients with melanoma: results of the Spanish Melanoma Group registry

The Spanish Melanoma Group (GEM) developed a national registry of patients with melanoma infected by SARS-CoV-2 ("GRAVID"). The main objective was to describe the COVID-19 fatality rate in patients with melanoma throughout the pandemic, as well as to explore the effect of melanoma treatmen...

Descripción completa

Detalles Bibliográficos
Autores: Gonzalez-Cao, Maria, Puertolas, Teresa, Martinez-Vila, Clara, Carrera, Cristina, Maldonado Seral, Cayetana, Rodriguez-Jimenez, Pedro, Sequero, Silvia, Cerezuela-Fuentes, Pablo, Feltes Ochoa, Rosa, Muñoz, Eva, Antoñanzas Basa, Mónica, Martín-Liberal, Juan, Soria, Ainara, Rodriguez-Moreno, Juan Francisco, Marquez-Rodas, Ivan, Lopez Criado, Pilar, Manzano, José Luis, Lopez-Castro, Rafael, Ayala de Miguel, Pablo, Villalobos, Laura, Martin Algarra, Salvador, Gonzalez-Barrallo, Ines, Boada, Aram, García Castaño, Almudena, Puig, Susana, Crespo, Guillermo, Luna Fra, Pablo, Aguayo Zamora, Cristina, Feito Rodriguez, Marta, Valles, Lara, Drozdowskyj, Ana, Gardeazabal, Jesús, Fernandez-Morales, Luis Antonio, Rodrigo, Alberto, Cruz, Raquel, Yelamos, Oriol, Rubio, Belen, Mujica, Karmele, Provencio, Mariano, Berrocal, Alfonso
Tipo de recurso: artículo
Fecha de publicación:2023
País:España
Institución:Conselleria de Salut i Consum del Govern de les Illes Balears
Repositorio:Docusalut
Idioma:inglés
OAI Identifier:oai:docusalut.com:20.500.13003/18876
Acceso en línea:https://hdl.handle.net/20.500.13003/18876
Access Level:acceso abierto
Palabra clave:Child
Aged, 80 and over
Aged
Diabetes Mellitus
Young Adult
SARS-CoV-2
Adult
Humans
Adolescent
Melanoma
Middle Aged
Male
Female
COVID-19
Registries
Femenino
Adolescente
Masculino
Humanos
Persona de Mediana Edad
Adulto Joven
Anciano
Anciano de 80 o más Años
Niño
Adulto
Sistema de Registros
id ES_d34d453c50209ef4e14f08ceab491d4e
oai_identifier_str oai:docusalut.com:20.500.13003/18876
network_acronym_str ES
network_name_str España
repository_id_str
spelling SARS-CoV-2 infection in patients with melanoma: results of the Spanish Melanoma Group registryGonzalez-Cao, MariaPuertolas, TeresaMartinez-Vila, ClaraCarrera, CristinaMaldonado Seral, CayetanaRodriguez-Jimenez, PedroSequero, SilviaCerezuela-Fuentes, PabloFeltes Ochoa, RosaMuñoz, EvaAntoñanzas Basa, MónicaMartín-Liberal, JuanSoria, AinaraRodriguez-Moreno, Juan FranciscoMarquez-Rodas, IvanLopez Criado, PilarManzano, José LuisLopez-Castro, RafaelAyala de Miguel, PabloVillalobos, LauraMartin Algarra, SalvadorGonzalez-Barrallo, InesBoada, AramGarcía Castaño, AlmudenaPuig, SusanaCrespo, GuillermoLuna Fra, PabloAguayo Zamora, CristinaFeito Rodriguez, MartaValles, LaraDrozdowskyj, AnaGardeazabal, JesúsFernandez-Morales, Luis AntonioRodrigo, AlbertoCruz, RaquelYelamos, OriolRubio, BelenMujica, KarmeleProvencio, MarianoBerrocal, AlfonsoChildAged, 80 and overAgedDiabetes MellitusYoung AdultSARS-CoV-2AdultHumansAdolescentMelanomaMiddle AgedMaleFemaleCOVID-19RegistriesAged, 80 and overFemeninoCOVID-19AdolescenteMasculinoMelanomaDiabetes MellitusHumanosPersona de Mediana EdadSARS-CoV-2Adulto JovenAncianoAnciano de 80 o más AñosNiñoAdultoSistema de RegistrosThe Spanish Melanoma Group (GEM) developed a national registry of patients with melanoma infected by SARS-CoV-2 ("GRAVID"). The main objective was to describe the COVID-19 fatality rate in patients with melanoma throughout the pandemic, as well as to explore the effect of melanoma treatment and tumor stage on the risk of COVID-19 complications. These are the final data of the register, including cases from February 2020 to September 2021. One hundred-fifty cases were registered. Median age was 68 years (range 6-95), 61 (40%) patients were females, and 63 (42%) patients had stage IV. Thirty-nine (26%) were on treatment with immunotherapy, and 17 (11%) with BRAF-MEK inhibitors. COVID-19 was resolved in 119 cases, including 85 (57%) patients cured, 15 (10%) that died due to melanoma, and 20 (13%) that died due to COVID-19. Only age over 60 years, cardiovascular disorders, and diabetes mellitus increased the risk of death due to COVID-19, but not advanced melanoma stage nor melanoma systemic therapies. Three waves have been covered by the register: February-May 2020, August-November 2020, and December 2020-April 2021. The first wave had the highest number of registered cases and COVID-19 mortality. Tumor stage or melanoma treatments are non-significant prognostic factors for COVID-19 mortality. During the pandemic in Spain there was a downward trend in the number of patients registered across the waves, as well as in the severity of the infection. NCT04344002.Springer20232023-03-0120232023-03-01research articlehttp://purl.org/coar/resource_type/c_2df8fbb1info:eu-repo/semantics/articleapplication/pdfhttps://hdl.handle.net/20.500.13003/18876reponame:Docusalutinstname:Conselleria de Salut i Consum del Govern de les Illes BalearsInglésengopen accesshttp://purl.org/coar/access_right/c_abf2Attribution-NonCommercial-NoDerivatives 4.0 Internacionalhttp://creativecommons.org/licenses/by-nc-nd/4.0/info:eu-repo/semantics/openAccessoai:docusalut.com:20.500.13003/188762026-06-22T12:44:07Z
dc.title.none.fl_str_mv SARS-CoV-2 infection in patients with melanoma: results of the Spanish Melanoma Group registry
title SARS-CoV-2 infection in patients with melanoma: results of the Spanish Melanoma Group registry
spellingShingle SARS-CoV-2 infection in patients with melanoma: results of the Spanish Melanoma Group registry
Gonzalez-Cao, Maria
Child
Aged, 80 and over
Aged
Diabetes Mellitus
Young Adult
SARS-CoV-2
Adult
Humans
Adolescent
Melanoma
Middle Aged
Male
Female
COVID-19
Registries
Aged, 80 and over
Femenino
COVID-19
Adolescente
Masculino
Melanoma
Diabetes Mellitus
Humanos
Persona de Mediana Edad
SARS-CoV-2
Adulto Joven
Anciano
Anciano de 80 o más Años
Niño
Adulto
Sistema de Registros
title_short SARS-CoV-2 infection in patients with melanoma: results of the Spanish Melanoma Group registry
title_full SARS-CoV-2 infection in patients with melanoma: results of the Spanish Melanoma Group registry
title_fullStr SARS-CoV-2 infection in patients with melanoma: results of the Spanish Melanoma Group registry
title_full_unstemmed SARS-CoV-2 infection in patients with melanoma: results of the Spanish Melanoma Group registry
title_sort SARS-CoV-2 infection in patients with melanoma: results of the Spanish Melanoma Group registry
dc.creator.none.fl_str_mv Gonzalez-Cao, Maria
Puertolas, Teresa
Martinez-Vila, Clara
Carrera, Cristina
Maldonado Seral, Cayetana
Rodriguez-Jimenez, Pedro
Sequero, Silvia
Cerezuela-Fuentes, Pablo
Feltes Ochoa, Rosa
Muñoz, Eva
Antoñanzas Basa, Mónica
Martín-Liberal, Juan
Soria, Ainara
Rodriguez-Moreno, Juan Francisco
Marquez-Rodas, Ivan
Lopez Criado, Pilar
Manzano, José Luis
Lopez-Castro, Rafael
Ayala de Miguel, Pablo
Villalobos, Laura
Martin Algarra, Salvador
Gonzalez-Barrallo, Ines
Boada, Aram
García Castaño, Almudena
Puig, Susana
Crespo, Guillermo
Luna Fra, Pablo
Aguayo Zamora, Cristina
Feito Rodriguez, Marta
Valles, Lara
Drozdowskyj, Ana
Gardeazabal, Jesús
Fernandez-Morales, Luis Antonio
Rodrigo, Alberto
Cruz, Raquel
Yelamos, Oriol
Rubio, Belen
Mujica, Karmele
Provencio, Mariano
Berrocal, Alfonso
author Gonzalez-Cao, Maria
author_facet Gonzalez-Cao, Maria
Puertolas, Teresa
Martinez-Vila, Clara
Carrera, Cristina
Maldonado Seral, Cayetana
Rodriguez-Jimenez, Pedro
Sequero, Silvia
Cerezuela-Fuentes, Pablo
Feltes Ochoa, Rosa
Muñoz, Eva
Antoñanzas Basa, Mónica
Martín-Liberal, Juan
Soria, Ainara
Rodriguez-Moreno, Juan Francisco
Marquez-Rodas, Ivan
Lopez Criado, Pilar
Manzano, José Luis
Lopez-Castro, Rafael
Ayala de Miguel, Pablo
Villalobos, Laura
Martin Algarra, Salvador
Gonzalez-Barrallo, Ines
Boada, Aram
García Castaño, Almudena
Puig, Susana
Crespo, Guillermo
Luna Fra, Pablo
Aguayo Zamora, Cristina
Feito Rodriguez, Marta
Valles, Lara
Drozdowskyj, Ana
Gardeazabal, Jesús
Fernandez-Morales, Luis Antonio
Rodrigo, Alberto
Cruz, Raquel
Yelamos, Oriol
Rubio, Belen
Mujica, Karmele
Provencio, Mariano
Berrocal, Alfonso
author_role author
author2 Puertolas, Teresa
Martinez-Vila, Clara
Carrera, Cristina
Maldonado Seral, Cayetana
Rodriguez-Jimenez, Pedro
Sequero, Silvia
Cerezuela-Fuentes, Pablo
Feltes Ochoa, Rosa
Muñoz, Eva
Antoñanzas Basa, Mónica
Martín-Liberal, Juan
Soria, Ainara
Rodriguez-Moreno, Juan Francisco
Marquez-Rodas, Ivan
Lopez Criado, Pilar
Manzano, José Luis
Lopez-Castro, Rafael
Ayala de Miguel, Pablo
Villalobos, Laura
Martin Algarra, Salvador
Gonzalez-Barrallo, Ines
Boada, Aram
García Castaño, Almudena
Puig, Susana
Crespo, Guillermo
Luna Fra, Pablo
Aguayo Zamora, Cristina
Feito Rodriguez, Marta
Valles, Lara
Drozdowskyj, Ana
Gardeazabal, Jesús
Fernandez-Morales, Luis Antonio
Rodrigo, Alberto
Cruz, Raquel
Yelamos, Oriol
Rubio, Belen
Mujica, Karmele
Provencio, Mariano
Berrocal, Alfonso
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
dc.contributor.none.fl_str_mv
dc.subject.none.fl_str_mv Child
Aged, 80 and over
Aged
Diabetes Mellitus
Young Adult
SARS-CoV-2
Adult
Humans
Adolescent
Melanoma
Middle Aged
Male
Female
COVID-19
Registries
Aged, 80 and over
Femenino
COVID-19
Adolescente
Masculino
Melanoma
Diabetes Mellitus
Humanos
Persona de Mediana Edad
SARS-CoV-2
Adulto Joven
Anciano
Anciano de 80 o más Años
Niño
Adulto
Sistema de Registros
topic Child
Aged, 80 and over
Aged
Diabetes Mellitus
Young Adult
SARS-CoV-2
Adult
Humans
Adolescent
Melanoma
Middle Aged
Male
Female
COVID-19
Registries
Aged, 80 and over
Femenino
COVID-19
Adolescente
Masculino
Melanoma
Diabetes Mellitus
Humanos
Persona de Mediana Edad
SARS-CoV-2
Adulto Joven
Anciano
Anciano de 80 o más Años
Niño
Adulto
Sistema de Registros
description The Spanish Melanoma Group (GEM) developed a national registry of patients with melanoma infected by SARS-CoV-2 ("GRAVID"). The main objective was to describe the COVID-19 fatality rate in patients with melanoma throughout the pandemic, as well as to explore the effect of melanoma treatment and tumor stage on the risk of COVID-19 complications. These are the final data of the register, including cases from February 2020 to September 2021. One hundred-fifty cases were registered. Median age was 68 years (range 6-95), 61 (40%) patients were females, and 63 (42%) patients had stage IV. Thirty-nine (26%) were on treatment with immunotherapy, and 17 (11%) with BRAF-MEK inhibitors. COVID-19 was resolved in 119 cases, including 85 (57%) patients cured, 15 (10%) that died due to melanoma, and 20 (13%) that died due to COVID-19. Only age over 60 years, cardiovascular disorders, and diabetes mellitus increased the risk of death due to COVID-19, but not advanced melanoma stage nor melanoma systemic therapies. Three waves have been covered by the register: February-May 2020, August-November 2020, and December 2020-April 2021. The first wave had the highest number of registered cases and COVID-19 mortality. Tumor stage or melanoma treatments are non-significant prognostic factors for COVID-19 mortality. During the pandemic in Spain there was a downward trend in the number of patients registered across the waves, as well as in the severity of the infection. NCT04344002.
publishDate 2023
dc.date.none.fl_str_mv 2023
2023-03-01
2023
2023-03-01
dc.type.none.fl_str_mv research article
http://purl.org/coar/resource_type/c_2df8fbb1
dc.type.openaire.fl_str_mv info:eu-repo/semantics/article
format article
dc.identifier.none.fl_str_mv https://hdl.handle.net/20.500.13003/18876
url https://hdl.handle.net/20.500.13003/18876
dc.language.none.fl_str_mv Inglés
eng
language_invalid_str_mv Inglés
language eng
dc.rights.none.fl_str_mv open access
http://purl.org/coar/access_right/c_abf2
Attribution-NonCommercial-NoDerivatives 4.0 Internacional
http://creativecommons.org/licenses/by-nc-nd/4.0/
dc.rights.openaire.fl_str_mv info:eu-repo/semantics/openAccess
rights_invalid_str_mv open access
http://purl.org/coar/access_right/c_abf2
Attribution-NonCommercial-NoDerivatives 4.0 Internacional
http://creativecommons.org/licenses/by-nc-nd/4.0/
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Springer
publisher.none.fl_str_mv Springer
dc.source.none.fl_str_mv reponame:Docusalut
instname:Conselleria de Salut i Consum del Govern de les Illes Balears
instname_str Conselleria de Salut i Consum del Govern de les Illes Balears
reponame_str Docusalut
collection Docusalut
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1869420447915835392
score 15,81155